13F Insight
DOSSIER · 13F Holders · Q2 2026

THERAVANCE BIOPHARMA INC

187 institutions still hold THERAVANCE BIOPHARMA INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP G8807B106·187 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$698M
visible holders
Holders
187
filers reporting
Concentration
22.43%
Madison Avenue Partners, LP #1
top holder share
AI Holders Summary · Q2 2026

187 institutions reported THERAVANCE BIOPHARMA INC in Q2 2026. Madison Avenue Partners, LP leads at 22.4% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Madison Avenue Partners, LP
CIK 0001801265
$157M9.2M6.74%Q2 202602
Weiss Asset Management LP
CIK 0001357550
$127M7.5M1.33%Q2 202603
BlackRock, Inc.
CIK 0002012383
$78M4.6M0.00%Q2 202604
Newtyn Management, LLC
CIK 0001569241
$58M3.4M7.29%Q2 202605
Irenic Capital Management LP
CIK 0001929389
$47M2.8M2.25%Q2 202606
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$30M1.8M0.00%Q2 202607
D. E. Shaw & Co., Inc.
CIK 0001009207
$24M1.3M0.01%Q4 202508
STATE STREET CORP
CIK 0000093751
$23M1.3M0.00%Q2 202609
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
$21M1.2M0.02%Q2 202610
ACADIAN ASSET MANAGEMENT LLC
CIK 0000916542
$21M1.3M0.03%Q1 202611
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$19M1.1M0.00%Q2 202612
DIMENSIONAL FUND ADVISORS LP
CIK 0000354204· Quasi-passive
$18M1.0M0.00%Q2 202613
MACKENZIE FINANCIAL CORP
CIK 0000919859
$17M986K0.02%Q2 202614
MORGAN STANLEY
CIK 0000895421
$12M705K0.00%Q2 202615
Oasis Management Co Ltd.
CIK 0001317904
$10M583K0.53%Q2 202616
CITADEL ADVISORS LLC
CIK 0001423053
$9M537K0.00%Q2 202617
UBS Group AG
CIK 0001610520
$8M488K0.00%Q2 202618
Qube Research & Technologies Ltd
CIK 0001729829
$7M430K0.01%Q2 202619
TWO SIGMA ADVISERS, LP
CIK 0001478735
$7M380K0.01%Q4 202520
NORTHERN TRUST CORP
CIK 0000073124· Index
$7M404K0.00%Q2 2026
Page 1 of 10
167 more holders available. Log in →